Kyushu University · Biochemistry, Genetics and Molecular Biology
Professor Yosuke Taniguchi's research lab specializes in the design and synthesis of novel nucleoside analogues for advanced DNA recognition and detection. The lab focuses on developing non-natural nucleosides that enable selective recognition of damaged DNA bases—particularly 8-oxo-2'-deoxyguanosine—without enzymatic or chemical pretreatment, leveraging unique fluorescent and stabilizing properties. Another key direction involves creating innovative scaffolds, such as W-shaped nucleoside analogues (WNA), to overcome limitations in triplex-forming oligonucleotides, especially at sequence-incompatible sites like TA or CG interruptions. The lab also explores shape-mimic nucleosides that replicate the mutagenic behavior of oxidatively damaged purines, providing tools for studying DNA damage and repair mechanisms.
Figures are computed from collected data and may differ slightly.
The effect of pressure on the trans–gauche equilibrium of 1,2-dichloroethane in n-hexane solution and of 1,2-dibromoethane in 2-methylbutane and acetonitrile solutions has been measured by the Raman spectrum. The relative integrated intensities of the carbon–halogen stretching vibrations of the two conformers has been taken as a measure of their relative concentrations. The volume change at the trans–gauche transformation for 1,2-dichloroethane is −3.8 ± ∼0.2 and −3.5 ± ∼0.2 cm3 mol−1, respectiv
The selective detection of 8-oxo-2'-deoxyguanosine (8-oxo-dG) in DNA without chemical or enzymatic treatment is an attractive tool for genomic research. We designed and synthesized the non-natural nucleoside analogue, the adenosine-1,3-diazaphenoxazine (Adap) derivative, for selective recognition of 8-oxo-dG in DNA. This study clearly showed that Adap has a highly selective stabilizing effect on the duplex containing the Adap-8-oxo-dG base pair. Furthermore, the fluorescent property of Adap was
The selective detection of 8-oxo-2′-deoxyguanosine (8-oxo-dG) in DNA without chemical or enzymatic treatment is an attractive tool for genomic research. We designed and synthesized the non-natural nucleoside analogue, the adenosine-1,3-diazaphenoxazine (Adap) derivative, for selective recognition of 8-oxo-dG in DNA. This study clearly showed that Adap has a highly selective stabilizing effect on the duplex containing the Adap–8-oxo-dG base pair. Furthermore, the fluorescent property of Adap was
Triplex-forming oligonucleotides (TFOs) are sequence-specific DNA-binding agents, but their target duplexes are limited to homopurine/homopyrimidine sequences because of interruption of the pyrimidines bases in the purine region. This problem has not been fully solved despite a wide variety of studies. Recently, we have developed a bicyclic system as a novel scaffold for nucleoside analogues (WNA, W-shaped nucleoside analogues) and determined two useful compounds, WNA-betaT (2) and WNA-betaC (5)
A substantial fraction of mutations that arise in the cell comes from oxidative damage to DNA bases. Oxidation of purine bases at the 8-position, yielding 8-oxo-G and 8-oxo-A, results in conformational changes (from anti to syn) that cause miscoding during DNA replication. Here we describe the synthesis and biophysical and biochemical properties of low-polarity shape mimics of 8-oxopurines, and we report that these new analogues exhibit remarkable mimicry of the mutagenic properties of the natur
The development of novel nucleoside analogues for the formation of triplex DNA containing pyrimidine-purine inversion sites has been a challenging field. In this paper, we describe the design and synthesis of non-natural nucleoside analogues, N-substituted-2'-deoxy-5-methylisocytidine derivatives, and their evaluation for triplex formation. It has been shown that N-(guanidinoethyl)-2'-deoxy-5-methylisocytidine exhibits selective recognition of a CG interrupting site and potentiates the formation
Some reports have described pleural lavage cytology (PLC) to be a prognostic factor for non-small cell lung cancer (NSCLC) patients. However, there have only been a few reports describing the findings both immediately after thoracotomy (PLC after thoracotomy) and before the closure of the chest (PLC before closure). From April 2002 to April 2008, both PLC after thoracotomy and PLC before closure were performed in 296 consecutive patients who underwent resections for NSCLC. PLC after thoracotomy
Sequence-specific recognition of duplex DNA mediated by triple helix formation offers a potential basis for oligonucleotide therapy and biotechnology. However, triplex formation is limited mostly to homopurine strands, due to poor stabilization at CG or TA base pairs in the target duplex DNA sequences. Several non-natural nucleosides have been designed for the recognition of CG or TA base pairs within an antiparallel triplex DNA. Nevertheless, problems including low selectivity and high dependen
Open papers in the app to read, cite, and organize with AI.